Abstract:There has been progressive realization of the international need to focus on non-communicable diseases: cardiovascular disease, cancer, chronic lung disease, and diabetes. The majority of deaths worldwide are caused by these conditions, and all share risk factors: diets high in rapidly absorbed carbohydrates, fats, and sodium; physical inactivity; shifts from areas of low to high population density; and exposure to tobacco, alcohol, and environmental pollutants.1 Non-communicable disease prevalence is increasing dramatically. In Saudi Arabia, among adults aged between 46 and 60 years, 10% have coronary heart disease and 49% diabetes, and the diabetes prevalence among adults increased from 13% in 1997 to 22% in 2004, and is now 32% of the population.2 In most of sub-Saharan Africa, the prevalence of diabetes was below 2% through the 1990s, but estimates at the beginning of the 21st century put its prevalence between 8% and 10%.3 While diabetes prevalence in Spain4 and in the USA5 doubled over the past three decades, its prevalence in Asia quadrupled.6 Developing countries may have specific risk factors for diabetes exceeding those for developed countries. Exposure in utero and during infancy to malnutrition during the Nigerian Civil War in the late 1960s led to three- and four-fold increases in the prevalence of hypertension and diabetes, respectively, four decades later.7 Similar studies of fetal and early life exposure to the Chinese famine in the late 1950s and early 1960s showed more than a doubling in the risk of dysglycemia in adult life, particularly in those individuals with Western dietary patterns and those with a greater adult body weight.8 Given the association of diabetes with dyslipidemia and hypertension,9 it should not be surprising that, in the developing world, diabetes leads to a doubling of coronary heart disease.10 Over the past two to three decades, China has grown in economic strength and prosperity, modernizing its industrial base and increasing education levels. From 1990 to 2000, the proportion of the population living in urban areas increased from 26% to 36%, with this proportion expected to increase to 45% by 2010, and to 60% by 2030.11 An undesirable accompanying transition has been the increase in the prevalence of chronic diseases, which now comprise 80% of total deaths in China,11 driven by urbanization in concert with the aging of the population, with projections for approximately one-quarter of the population, some 400 million persons, to be aged 60 years or more by the mid-twenty-first century.1 Until recently, diabetes played a relatively small part in the burden of chronic disease in China, causing 2% of annual deaths and 1% of disease-related loss of productivity.11 Diabetes links strongly, however, with aging, with obesity, and with the move from rural to urban communities. In 2002, diabetes was present in 1% of persons living in poor rural communities, but approximately 6% of those living in urban areas, in association with higher levels of obesity.11 The population prevalence of diabetes in China was estimated at <1.5% in 1986 and around 3% in 1996 and 1997.12–14 Based on this data, estimates were made that, by 2025–2030, there would be approximately 40 million persons in China with diabetes.12,15 In 2006, however, diabetes prevalence exceeded 5%.16 Two current reports give far greater estimates. The China National Diabetes and Metabolic Disorders Study Group survey, carried out in 2007–2008, found diabetes in 9.7% of the adult population, based on glucose tolerance testing of 46 239 adults. In 60.7%, diabetes had been undiagnosed. An additional 15.5% of adults had abnormal glucose tolerance.17 The even larger Chinese National Diabetes Survey, conducted in 162 cites, representing all 31 regions of the country, in 2010 found an identical diabetes prevalence of 9.7% among the 96 939 participants aged 18 years or older, with urban and rural prevalences of 11.2% and 8.4%, respectively, with 63.9% not previously diagnosed, and with 16.2% having pre-diabetes.18 Both studies confirmed the increase in diabetes prevalence with age, with approximately 20% of the Chinese population older than 60 years having diabetes, approaching the 25% prevalence of diabetes among adults in the US aged 65–95 years.19 A United Nations General Assembly addressing non-communicable disease prevention and control met on 19 and 20 September 2011 in New York, focusing on the need for intervention by governments, industry, and society to curb tobacco consumption, to reduce marketing to children of foods and beverages that are high in saturated fats, trans-fatty acids, sugars, or salt, to decrease harmful consumption of alcohol, and overall to promote healthy diets and physical activity.20 The common experience of those treating diabetes is that lifestyle change is crucial, but all-too-infrequently achieved, and that it requires the creation of a therapeutic alliance between patient and caregiver. We need more use of appropriate treatments,21 and we need to develop novel tactics to improve adherence.22 Recognizing the burden of diabetes, increasing from approximately 150–350 million persons worldwide over the past three decades,23 approaches used for communicable diseases deserve consideration in the treatment of diabetes. Treatment both of diabetes, like that of chronic infections, may face inadequacies of personnel, infrastructure, and drug supply, so that community involvement can play a crucial role in achieving reasonable treatment results.24 As with communicable diseases, we need to assess patients presenting with diabetes, establish reasonable targets based on treatment protocols combining lifestyle intervention and pharmacologic agents, and systematically monitor outcomes25 to control the growing epidemic.

China Diabetes Society 2016: A Call for Papers

China—leading the Way in Diabetes Research

Changing Epidemiology of Metabolic Syndrome and Type 2 Diabetes in Chinese Youth

Chinese Childrens’ Diabetes Status, Trends and Hardship

Paediatric type 2 diabetes in China—Pandemic, progression, and potential solutions

Pediatric Diabetes in China: Challenges and Actions

Standards of medical care for type 2 diabetes in China 2019

Diabetes in China: a Societal Solution for a Personal Challenge.

Evolution in the Chinese Diabetes Society Standards of Care for Type 2 Diabetes.

Diabetes Research in China: Making Progress.

Hot Topics on Diabetes in China

Diabetes in China Part 2: Prevention, Challenges, and Progress

Standards of Care for Type 2 Diabetes in China

Diabetes: the Prototypical Non‐communicable Disease

Progress in diabetes research in China.

Diabetes Metabolism: Research and Reviews--Chinese Diabetes Society Special Issue: a Small but Encouraging Step Toward the Successful Control of Diabetes in China.

A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope

Epidemiology of diabetes and diabetic complications in China

Abstract 011: Prevalence and Control of Diabetes in Chinese Adults: the China Metabolic Risk Factor Study

The Diabetes Epidemic in China: an Integrated Review of National Surveys

Meeting the Challenge of Diabetes in China